Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1987 Jan;63(735):5–9. doi: 10.1136/pgmj.63.735.5

Cancer chemotherapy agent-induced perivenous extravasation injuries.

A Banerjee 1, T M Brotherston 1, B G Lamberty 1, R C Campbell 1
PMCID: PMC2428186  PMID: 3313357

Full text

PDF
5

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barlock A. L., Howser D. M., Hubbard S. M. Nursing management of adriamycin extravasation. Am J Nurs. 1979 Jan;79(1):94–96. [PubMed] [Google Scholar]
  2. Bowers D. G., Jr, Lynch J. B. Adriamycin extravasation. Plast Reconstr Surg. 1978 Jan;61(1):86–92. doi: 10.1097/00006534-197801000-00015. [DOI] [PubMed] [Google Scholar]
  3. Chait L. A., Dinner M. I. Ulceration caused by cytotoxic drugs. S Afr Med J. 1975 Nov 1;49(46):1935–1936. [PubMed] [Google Scholar]
  4. Cohen F. J., Manganaro J., Bezozo R. C. Identification of involved tissue during surgical treatment of doxorubicin-induced extravasation necrosis. J Hand Surg Am. 1983 Jan;8(1):43–45. doi: 10.1016/s0363-5023(83)80050-1. [DOI] [PubMed] [Google Scholar]
  5. Coleman J. J., 3rd, Walker A. P., Didolkar M. S. Treatment of adriamycin-induced skin ulcers: a prospective controlled study. J Surg Oncol. 1983 Feb;22(2):129–135. doi: 10.1002/jso.2930220217. [DOI] [PubMed] [Google Scholar]
  6. Desai M. H., Teres D. Prevention of doxorubicin-induced skin ulcers in the rat and pig with dimethyl sulfoxide (DMSO). Cancer Treat Rep. 1982 Jun;66(6):1371–1374. [PubMed] [Google Scholar]
  7. Donaldson S. S., Glick J. M., Wilbur J. R. Letter: Adriamycin activating a recall phenomenon after radiation therapy. Ann Intern Med. 1974 Sep;81(3):407–408. doi: 10.7326/0003-4819-81-3-407. [DOI] [PubMed] [Google Scholar]
  8. Dorr R. T., Alberts D. S. Pharmacologic antidotes to experimental doxorubicin skin toxicity: a suggested role for beta-adrenergic compounds. Cancer Treat Rep. 1981 Nov-Dec;65(11-12):1001–1006. [PubMed] [Google Scholar]
  9. Dragon L. H., Braine H. G. Necrosis of the hand after daunorubicin infusion distal to an arteriovenous fistula. Ann Intern Med. 1979 Jul;91(1):58–59. doi: 10.7326/0003-4819-91-1-58. [DOI] [PubMed] [Google Scholar]
  10. Hankin F. M., Louis D. S. Surgical management of doxorubicin (Adriamycin) extravasation. J Pediatr Orthop. 1984 Jan;4(1):96–99. doi: 10.1097/01241398-198401000-00018. [DOI] [PubMed] [Google Scholar]
  11. Huang T. T., Lynch J. B., Larson D. L., Lewis S. R. The use of excisional therapy in the management of snakebite. Ann Surg. 1974 May;179(5):598–607. doi: 10.1097/00000658-197405000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ignoffo R. J., Friedman M. A. Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treat Rev. 1980 Mar;7(1):17–27. doi: 10.1016/s0305-7372(80)80023-5. [DOI] [PubMed] [Google Scholar]
  13. Larson D. L. What is the appropriate management of tissue extravasation by antitumor agents? Plast Reconstr Surg. 1985 Mar;75(3):397–405. doi: 10.1097/00006534-198503000-00017. [DOI] [PubMed] [Google Scholar]
  14. Laughlin R. A., Landeen J. M., Habal M. B. The management of inadvertent subcutaneous adriamycin infiltration. Am J Surg. 1979 Mar;137(3):408–412. doi: 10.1016/0002-9610(79)90077-1. [DOI] [PubMed] [Google Scholar]
  15. Linder R. M., Upton J., Osteen R. Management of extensive doxorubicin hydrochloride extravasation injuries. J Hand Surg Am. 1983 Jan;8(1):32–38. doi: 10.1016/s0363-5023(83)80048-3. [DOI] [PubMed] [Google Scholar]
  16. Linder R. M., Upton J., Osteen R. Management of extensive doxorubicin hydrochloride extravasation injuries. J Hand Surg Am. 1983 Jan;8(1):32–38. doi: 10.1016/s0363-5023(83)80048-3. [DOI] [PubMed] [Google Scholar]
  17. Luedke D. W., Kennedy P. S., Rietschel R. L. Histopathogenesis of skin and subcutaneous injury induced by adriamycin. Plast Reconstr Surg. 1979 Apr;63(4):463–465. doi: 10.1097/00006534-197904000-00003. [DOI] [PubMed] [Google Scholar]
  18. Lynch D. J., Key J. C., White R. R., 4th Management and prevention of infiltration and extravasation injury. Surg Clin North Am. 1979 Oct;59(5):939–949. doi: 10.1016/s0039-6109(16)41940-7. [DOI] [PubMed] [Google Scholar]
  19. Mamakos M. S. Recall phenomenon or severe skin and muscle necrosis following Adriamycin extravasation in the hand. Int Surg. 1984 Jan-Mar;69(1):73–74. [PubMed] [Google Scholar]
  20. Myers C. E., McGuire W., Young R. Adriamycin: amelioration of toxicity by alpha-tocopherol. Cancer Treat Rep. 1976 Jul;60(7):961–962. [PubMed] [Google Scholar]
  21. Olver I. N., Schwarz M. A. Use of dimethyl sulfoxide in limiting tissue damage caused by extravasation of doxorubicin. Cancer Treat Rep. 1983 Apr;67(4):407–408. [PubMed] [Google Scholar]
  22. Ostrowski M. J. An unusual allergic reaction in a vein following intravenous adriamycin. Clin Oncol. 1976 Jun;2(2):179–180. [PubMed] [Google Scholar]
  23. Petro J. A., Graham W. P., 3rd, Miller S. H., Overholt T., Fallon T. Experimental and clinical studies of ulcers induced with adriamycin. Surg Forum. 1979;30:535–537. [PubMed] [Google Scholar]
  24. Reilly J. J., Neifeld J. P., Rosenberg S. A. Clinical course and management of accidental adriamycin extravasation. Cancer. 1977 Nov;40(5):2053–2056. doi: 10.1002/1097-0142(197711)40:5<2053::aid-cncr2820400509>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  25. Reilly J. J., Neifeld J. P., Rosenberg S. A. Clinical course and management of accidental adriamycin extravasation. Cancer. 1977 Nov;40(5):2053–2056. doi: 10.1002/1097-0142(197711)40:5<2053::aid-cncr2820400509>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  26. Rudolph R., Stein R. S., Pattillo R. A. Skin ulcers due to adriamycin. Cancer. 1976 Sep;38(3):1087–1094. doi: 10.1002/1097-0142(197609)38:3<1087::aid-cncr2820380308>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  27. Rudolph R., Suzuki M., Luce J. K. Experimental skin necrosis produced by adriamycin. Cancer Treat Rep. 1979 Apr;63(4):529–537. [PubMed] [Google Scholar]
  28. Rudolph R., Suzuki M., Luce J. K. Experimental skin necrosis produced by adriamycin. Cancer Treat Rep. 1979 Apr;63(4):529–537. [PubMed] [Google Scholar]
  29. Rudolph R., Woodward M., Hurn I. Ultrastructure of doxorubicin (adriamycin)-induced skin ulcers in rats. Cancer Res. 1979 Sep;39(9):3689–3693. [PubMed] [Google Scholar]
  30. Silvestrini R., Gambarucci C., Dasdia T. Attività biologica dell'adriamicina in vitro. Tumori. 1970 May-Jun;56(3):137–148. doi: 10.1177/030089167005600301. [DOI] [PubMed] [Google Scholar]
  31. Souhami L., Feld R. Urticaria following intravenous doxorubicin administration. JAMA. 1978 Oct 6;240(15):1624–1626. [PubMed] [Google Scholar]
  32. Tully J. L., Friedland G. H., Baldini L. M., Goldmann D. A. Complications of intravenous therapy with steel needles and Teflon catheters. A comparative study. Am J Med. 1981 Mar;70(3):702–706. doi: 10.1016/0002-9343(81)90600-8. [DOI] [PubMed] [Google Scholar]
  33. Upton J., Mulliken J. B., Murray J. E. Major intravenous extravasation injuries. Am J Surg. 1979 Apr;137(4):497–506. doi: 10.1016/0002-9610(79)90121-1. [DOI] [PubMed] [Google Scholar]
  34. Vogelzang N. J. "Adriamycin flare": a skin reaction resembling extravasation. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2067–2069. [PubMed] [Google Scholar]
  35. Wang J. J., Cortes E., Sinks L. F., Holland J. F. Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease. Cancer. 1971 Oct;28(4):837–843. doi: 10.1002/1097-0142(1971)28:4<837::aid-cncr2820280406>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  36. Zweig J. I., Kabakow B. An apparently effective countermeasure for doxorubicin extravasation. JAMA. 1978 May 19;239(20):2116–2116. doi: 10.1001/jama.1978.03280470028013. [DOI] [PubMed] [Google Scholar]
  37. Zweig J. I., Kabakow B., Wallach R. C., Valencic M., Zalusky R. Rational effective medical treatment of skin ulcers due to adriamycin. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2101–2103. [PubMed] [Google Scholar]
  38. Zweig J. I., Kabakow B., Wallach R. C., Valencic M., Zalusky R. Rational effective medical treatment of skin ulcers due to adriamycin. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2101–2103. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES